High Prevalence of Potential Molecular Therapeutic Targets in Poorly Differentiated Thyroid Carcinoma.

Endocr Pathol · 2025 · PMC12546271 · PMID 41123735

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

failed to reach statistical significanceno p-value reported

TP53 -mutated and non- NRAS /non- TP53- mutated groups showed a higher proportion of cases with adverse outcome (alive with disease status or death because of cancer), but survival analyses failed to reach statistical significance.

also in 6,035 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.